TriSalus Life Sciences
TLSI
6 hedge funds and large institutions have $9.48M invested in TriSalus Life Sciences in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
40% less funds holding
Funds holding: 10 → 6 (-4)
41.82% less ownership
Funds ownership: 88.16% → 46.34% (-42%)
48% less capital invested
Capital invested by funds: $18.3M → $9.48M (-$8.8M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
+$109K |
| 2 |
PCM
PenderFund Capital Management
Vancouver,
British Columbia, Canada
|
+$18.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$4.64M |
| 2 |
DFCM
Dark Forest Capital Management
San Juan,
Puerto Rico
|
-$3.56M |
| 3 |
GCWM
Graham Capital Wealth Management
Washington D.c.,
District of Columbia
|
-$705K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$164K |
| 5 |
VF
Virtu Financial
New York
|
-$106K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MF
1
Magnetar Financial
Evanston,
Illinois
| $7.34M | -$4.64M | -445,828 | -39% |
|
|
SIA
2
SkyView Investment Advisors
Shrewsbury,
New Jersey
| $1.57M | – | – | – |
|
|
MC
3
Meteora Capital
Boca Raton,
Florida
| $362K | +$109K | +10,491 | +44% |
|
4
Geode Capital Management
Boston,
Massachusetts
| $181K | – | – | – |
|
|
PCM
5
PenderFund Capital Management
Vancouver,
British Columbia, Canada
| $25K | +$18.4K | +1,768 | New |
|
6
UBS Group
Zurich,
Switzerland
| $231 | -$936 | -90 | -80% |
|
|
DFCM
7
Dark Forest Capital Management
San Juan,
Puerto Rico
| – | -$3.56M | -348,547 | Closed |
|
|
BFM
8
Boothbay Fund Management
New York
| – | -$164K | -15,980 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$106K | -10,347 | Closed |
|
|
GCWM
10
Graham Capital Wealth Management
Washington D.c.,
District of Columbia
| – | -$705K | -6,893 | Closed |
|
|
CS
11
Clear Street
New York
| – | -$663 | -65 | Closed |
|
TLSI Hedge Fund Activity: Q2 2023 in Review
6 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q2 2023, worth a combined $9.48M — down 48% from $18.3M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of TLSI and 1 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Meteora Capital, adding an estimated $109K. The largest seller was Magnetar Financial, cutting an estimated $4.64M.
- 6 institutional investors held TriSalus Life Sciences (TLSI) as of Q2 2023, down from 10 in Q1 2023.
- Funds reported $9.48M of TriSalus Life Sciences stock for Q2 2023, down 48% quarter-over-quarter.
- 1 fund opened new TriSalus Life Sciences positions in Q2 2023 and 5 closed out, a net change of -4 holders.
- The largest TriSalus Life Sciences buyer in Q2 2023 was Meteora Capital, an estimated $109K added.
- The largest TriSalus Life Sciences seller in Q2 2023 was Magnetar Financial, an estimated $4.64M sold.
Based on aggregated 13F filings for Q2 2023.